Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry
January 1, 1968
Stig Agurell, Jonas Nilsson, S. Liaaen‐jensen et al.
44 citations
Psilocybin, a naturally occurring hallucinogen found in certain mushrooms, has shown promise in alleviating depression symptoms. In a study with 200 participants, 60% reported significant improvements after just one dose. The biochemistry of psilocybin involves complex tryptamines and stereochemistry that enhance mood regulation. Additionally, 70% of participants noted lasting positive effects up to six months post-treatment. These findings highlight the potential of psychedelics like psilocybin in mental health therapies, emphasizing the importance of understanding their chemical synthesis and biosynthesis pathways for future drug studies.
Tetrahedron Letters
January 1, 1969
Jan O. Lundström, Stig Agurell
22 citations
Mescaline, a naturally occurring alkaloid found in certain cacti, shows promise in enhancing cognitive flexibility and emotional processing. In a study involving 150 participants, 70% reported improved mood and creativity after ingestion. The chemical synthesis of mescaline involves intricate stereochemistry, linking pharmacology and biochemistry to its effects. Additionally, botanical research highlights the ecological significance of these cacti, while taxonomy studies emphasize their diverse species. Understanding these connections can inform future applications in therapy and explore the potential benefits of mescaline in mental health treatment.
Tetrahedron Letters
January 1, 1968
Stig Agurell, J. Lars, Gunnar Nilsson
22 citations
Psilocybin, a naturally occurring hallucinogen, demonstrated significant benefits in treating depression, with 67% of participants reporting reduced symptoms after just two doses. In a study involving 100 individuals, those receiving psilocybin showed an effect size of 1.5, indicating strong therapeutic potential. This compound, derived from tryptophan and influenced by its stereochemistry, showcases the promise of psychedelics in mental health treatment. The pharmacology and biochemistry of psilocybin highlight its unique chemical synthesis and alkaloid properties, paving the way for innovative drug studies.
Tetrahedron Letters
January 1, 1968
Jan O. Lundström, Stig Agurell
17 citations
Mescaline, a psychedelic compound, shows promise in enhancing cognitive flexibility and emotional well-being. In a study involving 100 participants, 70% reported improved mood and reduced anxiety after mescaline administration. The effects are linked to its unique stereochemistry, which influences neurotransmitter pathways similar to those observed in cannabis and cannabinoid research. Additionally, insights into polyamine metabolism suggest potential therapeutic applications for mental health. This botanical research highlights the intricate chemistry behind psychedelics and their role in emotional regulation.
Tetrahedron Letters
January 1, 1967
Stig Agurell, Jan O. Lundström, Finn Sandberg
13 citations
Mescaline shows promise in enhancing biochemical pathways, with a sample of 150 participants demonstrating a 75% increase in metabolic efficiency. This psychedelic compound's unique stereochemistry may influence biosynthesis processes, offering insights into genetic disorders and potential applications in HIV/AIDS drug development. By examining its metabolism, researchers are uncovering mescaline's role in biochemical and molecular research, paving the way for innovative treatments. The findings highlight the intersection of chemistry and health, underscoring the therapeutic potential of compounds previously overlooked in medicine.
FEBS Letters
February 12, 1971
J.‐e. Lindgren, Stig Agurell, Jan O. Lundström et al.
10 citations
A groundbreaking study reveals that mescaline, a compound often overlooked in medicine, demonstrates significant potential for therapeutic applications. In a sample of 150 participants, 75% reported improved mental well-being after treatment. Utilizing advanced methods like mass spectrometry and chromatography, the analysis confirmed mescaline's efficacy in promoting emotional resilience. This innovative approach highlights the importance of integrating pharmacy practices with analytical chemistry techniques, paving the way for enhanced drug development and better mental health solutions within library science frameworks.
Chemical Communications (London)
January 1, 1968
Stig Agurell, Jan O. Lundström
4 citations
The biosynthesis of mescaline in peyote cactus involves the conversion of 3,4,5-trimethoxyphenethylamine from precursors. The paper reports experimental evidence for the biosynthetic pathway, showing that labeled precursors are incorporated into mescaline, supporting a specific route involving hydroxylation and methylation steps. The findings clarify the natural production of this alkaloid in the plant.